Tyra Biosciences Stock Market Value
TYRA Stock | USD 11.50 0.76 7.08% |
Symbol | Tyra |
Tyra Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tyra Biosciences. If investors know Tyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tyra Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tyra Biosciences is measured differently than its book value, which is the value of Tyra that is recorded on the company's balance sheet. Investors also form their own opinion of Tyra Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Tyra Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tyra Biosciences' market value can be influenced by many factors that don't directly affect Tyra Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tyra Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tyra Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tyra Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Tyra Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tyra Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tyra Biosciences.
12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Tyra Biosciences on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Tyra Biosciences or generate 0.0% return on investment in Tyra Biosciences over 90 days. Tyra Biosciences is related to or competes with Connect Biopharma, RAPT Therapeutics, Xilio Development, Mineralys Therapeutics,, Monte Rosa, Design Therapeutics, and Erasca. Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor... More
Tyra Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tyra Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tyra Biosciences upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.1) | |||
Maximum Drawdown | 15.45 | |||
Value At Risk | (4.81) | |||
Potential Upside | 7.08 |
Tyra Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tyra Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tyra Biosciences' standard deviation. In reality, there are many statistical measures that can use Tyra Biosciences historical prices to predict the future Tyra Biosciences' volatility.Risk Adjusted Performance | (0.10) | |||
Jensen Alpha | (0.31) | |||
Total Risk Alpha | (0.01) | |||
Treynor Ratio | (0.38) |
Tyra Biosciences Backtested Returns
Tyra Biosciences owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.11, which indicates the firm had a -0.11 % return per unit of risk over the last 3 months. Tyra Biosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Tyra Biosciences' Risk Adjusted Performance of (0.10), coefficient of variation of (794.13), and Variance of 11.09 to confirm the risk estimate we provide. The entity has a beta of 1.13, which indicates a somewhat significant risk relative to the market. Tyra Biosciences returns are very sensitive to returns on the market. As the market goes up or down, Tyra Biosciences is expected to follow. At this point, Tyra Biosciences has a negative expected return of -0.39%. Please make sure to validate Tyra Biosciences' kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if Tyra Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.37 |
Poor reverse predictability
Tyra Biosciences has poor reverse predictability. Overlapping area represents the amount of predictability between Tyra Biosciences time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tyra Biosciences price movement. The serial correlation of -0.37 indicates that just about 37.0% of current Tyra Biosciences price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.37 | |
Spearman Rank Test | -0.43 | |
Residual Average | 0.0 | |
Price Variance | 1.38 |
Tyra Biosciences lagged returns against current returns
Autocorrelation, which is Tyra Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Tyra Biosciences' stock expected returns. We can calculate the autocorrelation of Tyra Biosciences returns to help us make a trade decision. For example, suppose you find that Tyra Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Tyra Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Tyra Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Tyra Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Tyra Biosciences stock over time.
Current vs Lagged Prices |
Timeline |
Tyra Biosciences Lagged Returns
When evaluating Tyra Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Tyra Biosciences stock have on its future price. Tyra Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Tyra Biosciences autocorrelation shows the relationship between Tyra Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Tyra Biosciences.
Regressed Prices |
Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Tyra Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tyra Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tyra Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tyra Biosciences Stock:Check out Tyra Biosciences Correlation, Tyra Biosciences Volatility and Tyra Biosciences Alpha and Beta module to complement your research on Tyra Biosciences. For information on how to trade Tyra Stock refer to our How to Trade Tyra Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Tyra Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.